An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe. The study is published in the Scientific Reports.
There is a prospect of a new type of antibiotics “turning off” the oxygen only to the harmful bacteria cells, not to human cells.
Scientists discovered how the E. coli bacterium can survive in the human gut – earlier the question how they breathe was a mystery to experts. Vitaliy Borisov, Senior Researcher, Doctor of Biological Sciences, Professor of the Russian Academy of Sciences, A.N. Belozersky Research Institute physical and chemical biology employee, the Lomonosov Moscow State University and one of the authors, explains that breathing E. coli uses special enzymes, which are absent in the human body. This means that the discovery of the scientists can contribute to the creation of new drugs, which will be detrimental to the bacteria without harming a human.
The energy for the vital activity of any organism comes from food, and is generated by the means of redox processes in the body. The food is converted into energy not directly but through intermediaries. First, the complex molecules are decomposed into simpler: proteins are decomposed into amino acids, fats – to fatty acids, carbohydrates – to monosaccharides. Oxidation of simpler molecules releases energy, which all is contained in the electrons.
The electrons passes to the respiratory chain with the so-called reducing equivalents (electron-carrying compound). They are NADH (nicotinamide adenine dinucleotide) and ubiquinol, also known as coenzyme Q. These two basic reducing equivalents fully cope with the processing of food: NADH is a water-soluble compound and ubiquinol is fat-soluble. Membranous enzymes accept electrons from reducing equivalents and transfer them to molecular oxygen.
The terminal cytochrome oxidase is the main membrane enzyme responsible for the human mitochondrial respiration and was thought to be used for the breath of E. coli as well. The scheme of oxidases action is simple: transferring electrons to molecular oxygen, reducing equivalents are oxidized again, and as a result “the energy currency” of the cell – the proton-moving force is generated.
‘If you stop breathing, you die just because oxygen does not flow to the oxidase, and it does not produce energy,’ said Vitaly Borisov.
The Escherichia coli bacterium lives in the gastrointestinal tract, where a lot of hydrogen sulfide is produced, which attenuates mitochondrial respiration. Free hydrogen sulfide inhibits cytochrome oxidase work. Its concentration exceeds several hundred times the minimum concentration required for substantial blocking of this enzyme. Hence, it seems that the E. coli bacterium cannot “breathe”, but despite that the bacteria somehow survive in the intestine. The researchers assumed that the breath in the presence of hydrogen sulfide is still possible, but due to other oxidase. The fact is that the breath in people and bacteria occur in different ways. Each cell in our body “breathes” due to the work of only the cytochrome-c oxidase, others we have not. However, the E. coli bacteria has two types of oxidase: bo-type cytochrome oxidase (analogue of “human” cytochrome-c oxidase) and completely different bd-type cytochromes.
‘Our hypothesis was that the bd-type oxidase (bd-I and bd-II) are more resistant to the hydrogen sulfide inhibition than the bo-type cytochrome oxidase,’ commented Vitaly Borisov.
To test this hypothesis scientists needed to learn how the sulfide presence in the environment affects the growth of the E. coli bacteria cells, which have only one terminal oxidase (bd-I, bd-II or bo) in the respiratory chain. a variety of biochemical, biophysical and microbiological methods and approaches were applied, as well as the method of the intended mutagenesis.
The hypothesis was fully confirmed.
‘Bo-oxidase’s activity is completely inhibited by the hydrogen sulfide, while the work of the bd-oxidases remains untouched by the H2S. Thus, in order to successfully produce the main types of “the energy currency” under a high concentration of hydrogen sulfide, the intestinal microflora inhabitants should use a unique type of terminal oxidases, which is missing in the cells of humans and animals,’ said Vitaly Borisov.
The discovery could be used in the future to develop medicines that regulate the intestinal microflora and relieving it from harmful bacteria. As human cells do not contain the bd-type oxidase, the question of the ability to combat disease-causing bacteria without causing harm to the human body becomes relevant. For example, the bacterium causing tuberculosis, which’s primarily membrane enzyme is also a bd-type oxidase, quickly gaining resistance to classical antibiotics. Through this study there is a prospect of a new type of antibiotics “turning off” the oxygen only to the harmful bacteria cells, not to human cells.
Learn more:Â Revolutionary Antibiotics that Will Save the World?
The Latest on: Revolutionary Antibiotics
[google_news title=”” keyword=”Revolutionary Antibiotics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Revolutionary Antibiotics
- Antibiotic Breakthrough: Revolutionary Chinese Study Paves Way for Superbug Defeating Drugson April 23, 2024 at 2:43 pm
New research reveals that fluorous lipopetides act as highly effective antibiotics. Bacterial infections resistant to multiple drugs, which no existing antibiotics can treat, represent a significant ...
- Revolutionary chronic wound treatment could help millions, reveals studyon April 23, 2024 at 8:30 am
An effective treatment for chronic wounds that does not involve antibiotics, but an ionised gas to activate a wound dressing, has been developed by a team of international scientists.
- 8 UTI Home Remedies Other Than Antibioticson April 22, 2024 at 4:59 pm
While antibiotics are the most effective treatment for a UTI, you can use these home remedies to help manage your symptoms. Share on Pinterest A UTI can cause symptoms like bloody urine and pain ...
- Mom, 33, Disabled After Antibiotic Causes Toxic 'Floxing' Reaction: 'Like a Bomb Had Gone Off in My Body' (Exclusive)on April 19, 2024 at 7:28 am
Hailey Sebert is raising awareness about fluoroquinolone toxicity — the rare and sometimes debilitating side effects from a certain class of antibiotics Courtesy of Hailey Sebert Hailey Sebert ...
- New antibiotics were underprescribed for hard-to-treat infections, study findson April 18, 2024 at 5:00 pm
Although U.S. regulators approved several new antibiotics for combating hard-to-treat bacteria during a recent five-year period, hospital doctors instead gave older, generic remedies to more than ...
- Study Finds Antibiotics Helps Immune Cells Identify Cancer Cellson April 17, 2024 at 2:21 am
Researchers have discovered that tetracycline antibiotics help the immune system to find cancer cells in a way that is different from current immunotherapies.
- A second green revolution?on April 16, 2024 at 5:01 pm
Farmers can benefit from up to five times milk productivity enhancement by methods such as selective breeding, and better veterinary care, while being careful not to fall into the trap of over-use of ...
- Antibiotics reveal a new way to fight canceron April 16, 2024 at 12:30 pm
Cancer cells grow and spread by hiding from the body's immune system. Immunotherapy allows the immune system to find and attack hidden cancer cells, helping cancer patients live longer lives. However, ...
- Antibiotics don't speed recovery from cough, study showson April 15, 2024 at 4:38 am
Doctors sometimes prescribe antibiotics to help treat a cough, but a new study shows the drugs won't help reduce the severity or duration of coughing -- even if a bacterial infection is the culprit.
- Wafer-thin, stretchy and strong as steel: could ‘miracle’ material graphene finally transform our world?on April 13, 2024 at 8:00 am
The material, discovered in 2004, was meant to be revolutionary. But only now is the technology coming of age ...
via Bing News